Supreme Court Upholds Access to Abortion Pill Mifepristone in Unanimous Vote
glamour.comBy and On Thursday, June 13, the Supreme Court affirmed the US Food and Drug Administration’s approval of the abortion pill mifepristone, thereby handing down its most important ruling on since its , the landmark decision that protected the national right to .In a 9-0 decision in FDA v.
Alliance for Hippocratic Medicine, the justices found that the plaintiffs of a lawsuit that sought to pull the drug off the market lacked standing—that is, they did not have the right to bring the case to court.“The plaintiffs do not prescribe or use mifepristone.
And FDA is not requiring them to do or refrain from doing anything. Rather, the plaintiffs want FDA to make mifepristone more difficult for other doctors to prescribe and for pregnant women to obtain,” Justice Brett Kavanaugh wrote in . “A plaintiff’s desire to make a drug less available for others does not establish standing to sue.
Nor do the plaintiffs’ other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA’s actions.”The Supreme Court’s decision puts an end to a tangle of legal disputes in the lower courts that has caused widespread confusion over the legal status of mifepristone.
Read more on glamour.com